투자정보
주주 가치 제고를 위한 지속적인 노력으로
주주 여러분과 함께 성장하는 유유제약이 되겠습니다.
Financial Statement
좌우로 움직여보세요.
(단위 : 원)
| Item | Dec. 2024 | Dec. 2023 | Dec. 2022 |
|---|---|---|---|
| Current Assets (Total) | 101,947,330,682 | 101,596,545,868 | 96,357,746,320 |
| Non-Current Assets (Total) | 105,740,068,323 | 96,616,980,899 | 98,847,326,468 |
| Total Assets | 207,687,399,005 | 198,213,526,767 | 195,205,072,788 |
| Current Liabilities (Total) | 64,479,826,927 | 49,975,202,561 | 64,315,528,099 |
| Non-Current Liabilities (Total) | 8,144,221,253 | 27,882,669,323 | 7,515,503,277 |
| Total Liabilities | 72,624,048,180 | 77,857,871,884 | 71,831,031,376 |
| Capital | 20,201,681,000 | 20,201,681,000 | 20,201,681,000 |
| Capital Surplus | 32,160,811,833 | 32,160,811,833 | 32,160,811,833 |
| Retained Earnings | 25,789,477,196 | 20,170,850,527 | 31,395,871,274 |
| Total Capital | 135,063,350,825 | 120,355,654,883 | 123,374,041,412 |
